1 Min Read
April 17 (Reuters) - Swedish Orphan Biovitrum AB (publ) :
* SOBI SAYS RECEIVED APPROVAL FROM HEALTH CANADA FOR ONCE-DAILY DOSING OF ORFADIN FOR TREATMENT OF HT-1 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.